Myriad Genetics to Release Second Quarter 2025 Financial Results听on August 5, 2025
Myriad Genetics (NASDAQ: MYGN), a molecular diagnostic testing and precision medicine company, has scheduled its second quarter 2025 earnings release and conference call for August 5, 2025. The financial results will be released after market close, followed by a conference call at 4:30 PM ET.
Management will discuss the company's Q2 2025 financial performance and provide a business update during the call. Investors can access the live webcast through Myriad's Investor Relations website, while those preferring telephone participation must register to receive dial-in details.
Myriad Genetics (NASDAQ: MYGN), azienda specializzata in test diagnostici molecolari e medicina di precisione, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 e la conference call per il 5 agosto 2025. I risultati saranno diffusi dopo la chiusura del mercato, seguiti da una conference call alle 16:30 ET.
Durante la chiamata, la direzione discuter脿 le performance finanziarie del secondo trimestre 2025 e fornir脿 un aggiornamento sulle attivit脿 aziendali. Gli investitori potranno seguire la diretta streaming tramite il sito delle Relazioni con gli Investitori di Myriad, mentre chi preferisce partecipare telefonicamente dovr脿 registrarsi per ricevere i dettagli di accesso.
Myriad Genetics (NASDAQ: MYGN), empresa de pruebas diagn贸sticas moleculares y medicina de precisi贸n, ha programado la publicaci贸n de sus resultados del segundo trimestre de 2025 y la conferencia telef贸nica para el 5 de agosto de 2025. Los resultados financieros se dar谩n a conocer despu茅s del cierre del mercado, seguidos de una conferencia telef贸nica a las 4:30 PM ET.
La direcci贸n discutir谩 el desempe帽o financiero del segundo trimestre de 2025 y ofrecer谩 una actualizaci贸n del negocio durante la llamada. Los inversores podr谩n acceder a la transmisi贸n en vivo a trav茅s del sitio web de Relaciones con Inversores de Myriad, mientras que quienes prefieran participar por tel茅fono deben registrarse para recibir los detalles de acceso.
Myriad Genetics (NASDAQ: MYGN)電� 攵勳瀽 歆勲嫧 瓴�靷� 氚� 鞝曤皜 鞚橅暀 須岇偓搿�, 2025雲� 2攵勱赴 鞁れ爜 氚滍憸 氚� 旎嵓霟办姢 旖滌潉 2025雲� 8鞗� 5鞚茧 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 鞛 瓴瓣臣電� 鞁滌灔 毵堦皭 頉� 氚滍憸霅橂┌, 鞚挫柎靹� 鞓ろ泟 4鞁� 30攵�(霃欕秬鞁滉皠)鞐� 旎嵓霟办姢 旖滌澊 歆勴枆霅╇媹雼�.
瓴届榿歆勳潃 韱淀檾 欷� 2025雲� 2攵勱赴 鞛 靹标臣毳� 雲检潣頃橁碃 靷梾 順勴櫓鞚� 鞐呺嵃鞚错姼頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� Myriad 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 鞝勴檾 彀胳棳毳� 鞗愴暊 瓴届毎 霌彪頃橃棳 鞝戩啀 鞝曤炒毳� 氚涭晞鞎� 頃╇媹雼�.
Myriad Genetics (NASDAQ : MYGN), soci茅t茅 sp茅cialis茅e dans les tests diagnostiques mol茅culaires et la m茅decine de pr茅cision, a programm茅 la publication des r茅sultats du deuxi猫me trimestre 2025 et la conf茅rence t茅l茅phonique pour le 5 ao没t 2025. Les r茅sultats financiers seront publi茅s apr猫s la cl么ture du march茅, suivis d'une conf茅rence t茅l茅phonique 脿 16h30 ET.
La direction discutera des performances financi猫res du deuxi猫me trimestre 2025 et fournira une mise 脿 jour sur les activit茅s lors de l'appel. Les investisseurs pourront acc茅der 脿 la diffusion en direct via le site des Relations Investisseurs de Myriad, tandis que ceux pr茅f茅rant participer par t茅l茅phone doivent s'inscrire pour recevoir les informations de connexion.
Myriad Genetics (NASDAQ: MYGN), ein Unternehmen f眉r molekulare Diagnostik und Pr盲zisionsmedizin, hat die Ver枚ffentlichung der Ergebnisse f眉r das zweite Quartal 2025 und die Telefonkonferenz f眉r den 5. August 2025 geplant. Die Finanzzahlen werden nach B枚rsenschluss ver枚ffentlicht, gefolgt von einer Telefonkonferenz um 16:30 Uhr ET.
Das Management wird w盲hrend des Anrufs die finanzielle Leistung des zweiten Quartals 2025 besprechen und ein Unternehmensupdate geben. Investoren k枚nnen den Live-Webcast 眉ber die Investor-Relations-Website von Myriad verfolgen, w盲hrend diejenigen, die telefonisch teilnehmen m枚chten, sich registrieren m眉ssen, um die Einwahldaten zu erhalten.
- None.
- None.
SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings conference call at 4:30pm ET on Tuesday, Aug. 5, 2025. The company鈥檚 quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company鈥檚 performance for the second quarter 2025.
A live webcast of the conference call can be accessed on Myriad鈥檚 Investor Relations website at . To participate in the live conference call via telephone, please register . Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at following the call.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit .
Investor Contact听
Matt Scalo听
(801) 584-3532听
听
Media Contact听
Kate Schraml
(224) 875-4493
FAQ
When will Myriad Genetics (MYGN) report Q2 2025 earnings?
How can investors access Myriad Genetics' Q2 2025 earnings call?
What time is Myriad Genetics' Q2 2025 earnings call?
Where can I find the replay of Myriad Genetics' Q2 2025 earnings call?
